SATB Homeobox 1 (SATB1) (Middle Region) Peptid
SATB1
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN983406
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für SATB Homeobox 1 (SATB1) (Middle Region) Peptid (ABIN983406)
Target
SATB1
(SATB Homeobox 1 (SATB1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- EVDVAEYKEE ELLKDLEESV QDKNTNTLFS VKLEEELSVE GNTDINTDLK
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SATB1 Antibody(ARP33363_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SATB1 (SATB Homeobox 1 (SATB1))
-
Hintergrund
-
SATB1 binds to DNA at special AT-rich sequences at nuclear matrix- or scaffold-associated regions. SATB1 was thought to recognize the sugar-phosphate structure of double-stranded DNA.
Alias Symbols: -
Protein Interaction Partner: BAZ1A,CASP6,CHD3,CUX1,EP300,GATA3,HDAC1,KAT2B,MTA2,POLR2J,SATB1,SMARCA5,UBE2I,BAZ1A,CHD4,CTBP1,CUX1,DYT10,HDAC1,HDAC2,KAT2B,MTA2,PML,POLR2J,SIN3A,SMARCA5,TAL1,UBE2I,tat
Protein Size: 763 -
Molekulargewicht
- 86 kDa
-
Gen-ID
- 6304
-
NCBI Accession
- NM_002971, NP_002962
-
UniProt
- Q01826
Target
-
Sie sind hier:
